.

Deeper Knowledge, Faster

  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Accenture
Boehringer Ingelheim
US Army
Farmers Insurance
Chinese Patent Office
Cerilliant
Deloitte
Citi
Healthtrust

Generated: June 27, 2017

DrugPatentWatch Database Preview

Perampanel - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for perampanel and what is the scope of perampanel patent protection?

Perampanel
is the generic ingredient in one branded drug marketed by Eisai Inc and is included in two NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Perampanel has eighty-nine patent family members in thirty-two countries.

There are five drug master file entries for perampanel. One supplier is listed for this compound.

Summary for Generic Name: perampanel

Tradenames:1
Patents:3
Applicants:1
NDAs:2
Drug Master File Entries: see list5
Suppliers / Packagers: see list1
Bulk Api Vendors: see list37
Clinical Trials: see list43
Patent Applications: see list85
Drug Prices:see low prices
DailyMed Link:perampanel at DailyMed

Pharmacology for Ingredient: perampanel

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eisai Inc
FYCOMPA
perampanel
TABLET;ORAL202834-001Oct 22, 2012RXYesNo6,949,571► SubscribeYY ► Subscribe
Eisai Inc
FYCOMPA
perampanel
TABLET;ORAL202834-006Oct 22, 2012RXYesYes► Subscribe► Subscribe
Eisai Inc
FYCOMPA
perampanel
TABLET;ORAL202834-003Oct 22, 2012RXYesNo► Subscribe► Subscribe
Eisai Inc
FYCOMPA
perampanel
TABLET;ORAL202834-002Oct 22, 2012RXYesNo8,772,497► SubscribeY ► Subscribe
Eisai Inc
FYCOMPA
perampanel
TABLET;ORAL202834-002Oct 22, 2012RXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: perampanel

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,939,5491,2-dihydropyridine compounds, manufacturing method thereof and use thereof► Subscribe
8,304,548Method for producing 1, 2-dihydropyridine-2-one compound► Subscribe
7,563,8111,2-dihydropyridine compounds, manufacturing method thereof and use thereof► Subscribe
9,045,426Method for producing 1,2-dihydropyridine-2-one compound► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: perampanel

Country Document Number Estimated Expiration
Norway2012021► Subscribe
China102382047► Subscribe
CroatiaP20130363► Subscribe
Spain2404697► Subscribe
United Kingdom0022483► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PERAMPANEL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00566Netherlands► SubscribePRODUCT NAME: PERAMPANEL, EEN ZOUT OF EEN HYDRAAT DAARVAN; REGISTRATION NO/DATE: EU/1/12/776/001 .... 016 20120723
2013017,C1764361Lithuania► SubscribePRODUCT NAME: PERAMPANELUM; REGISTRATION NO/DATE: EU/1/12/776/001 - EU/1/12/776/016, 2012 07 23 EU/1/12/776/017 - EU1/12/776/023 20121029
12/049Ireland► SubscribePRODUCT NAME: PERAMPANEL, OPTIONALLY A SALT OR HYDRATE THEREOF.; REGISTRATION NO/DATE: EU/1/12/776/001-EU/1/12/776/016 20120723
0Finland► Subscribe
0130021 00081Estonia► SubscribePRODUCT NAME: PERAMPANEEL;REG NO/DATE: K(2012)5340 LOPLIK 23.07.2012
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Citi
AstraZeneca
Cantor Fitzgerald
Express Scripts
Daiichi Sankyo
Fuji
Healthtrust
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot